BRIEF-Amgen receives positive CHMP opinion to extend indication of Kyprolis
May 27, 2016 at 07:31 AM EDT
* Amgen receives positive CHMP opinion to extend indication of Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma